APP and memory impairment: Further, our conclusion that chronic ethosuximide administration does not reverse memory impairments in APP/PS1 mice is important as, apart from its antiepileptic effects, ethosuximide has previously been shown to have neuroprotective properties and thus is seen as a candidate to alleviate aging and age-related disease.